Additionally, it is projected that during the forecast period this segment will expand the fastest. The main factors anticipated to propel the demand for cannabis testing services include increasing quality checks for cannabinoids to ensure appropriate labelling of products in the medical and recreational sectors and their increased exports to nations where the market is heavily controlled. Additionally, potency testing services keep customers well-informed about the product's quality, which is driving the expansion of this market for US Cannabis Testing Services throughout the anticipated time.The cannabis drug makers segment, on the other hand, is anticipated to experience the quickest growth over the projection period. The main drivers of the segment's growth are the expanding acceptance of marijuana as a medicine and the increase in cannabis-based clinical trials by major pharma companies like Sanofi, Solvay Pharmaceuticals, and Pfizer.
Click Here For the US Cannabis Testing Services Market Press Release